Skip to main content
Erschienen in: Rheumatology International 8/2018

06.06.2018 | Review

The emerging role of cardiovascular magnetic resonance imaging in the assessment of cardiac involvement in juvenile idiopathic arthritis

verfasst von: Sophie Mavrogeni, Lambros Fotis, Loukia Koutsogeorgopoulou, Vasiliki Vartela, Vana Papaevangelou, Genovefa Kolovou

Erschienen in: Rheumatology International | Ausgabe 8/2018

Einloggen, um Zugang zu erhalten

Abstract

Juvenile idiopathic arthritis (JIA) is the commonest rheumatic disease in childhood and presents several subtypes according to the ILAR classification. JIA, specifically in its systemic form, may seriously damage various structures of the cardiovascular system. Other JIA phenotypes are also of interest, as cardiovascular disease (CVD) is underestimated and understudied, but chronic systemic inflammation and risk factors remained important contributors for CVD development. The currently applied non-invasive modalities, although they are important for the initial evaluation of JIA patients, frequently fail to detect the silent, subclinical forms of CVD. Cardiovascular magnetic resonance (CMR), due to its multifaceted capability in the detection of cardiovascular disease, can offer early, reproducible, non-invasive information about cardiovascular disease in JIA, allowing risk stratification and timely initiation /modification of cardiologic and anti-rheumatic treatment. However, lack of availability/expertise and high cost still hamper its application in the clinical cardio-rheumatic practice. The aim of the current article is to present an overview of CVD in JIA emphasizing the emerging role of CMR in early diagnosis and treatment follow-up of CVD in JIA patients.
Literatur
1.
Zurück zum Zitat Ravelli A, Martini A (2007) Juvenile idiopathic arthritis. Lancet 369:76778CrossRef Ravelli A, Martini A (2007) Juvenile idiopathic arthritis. Lancet 369:76778CrossRef
2.
Zurück zum Zitat Symmons DP, Jones M, Osborne J et al (1996) Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register. J Rheumatol 23:197580 Symmons DP, Jones M, Osborne J et al (1996) Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register. J Rheumatol 23:197580
3.
Zurück zum Zitat Petty RE, Southwood TR, Manners P et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:3902 Petty RE, Southwood TR, Manners P et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:3902
4.
Zurück zum Zitat Nigrovic PA, Raychaudhuri S, Thompson SD (2018) Review: genetics and the classification of arthritis in adults and children. Arthritis Rheumatol 70(1):7–17CrossRef Nigrovic PA, Raychaudhuri S, Thompson SD (2018) Review: genetics and the classification of arthritis in adults and children. Arthritis Rheumatol 70(1):7–17CrossRef
5.
Zurück zum Zitat Minden K, Niewerth M, Listing J et al (2002) Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum 46:2392401CrossRef Minden K, Niewerth M, Listing J et al (2002) Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum 46:2392401CrossRef
6.
Zurück zum Zitat Zak M, Pedersen FK (2000) Juvenile chronic arthritis into adulthood: a long-term follow-up study. Rheumatology 39:198–204CrossRef Zak M, Pedersen FK (2000) Juvenile chronic arthritis into adulthood: a long-term follow-up study. Rheumatology 39:198–204CrossRef
7.
Zurück zum Zitat Bohr AH, Fuhlbrigge RC, Pedersen FK, de Ferranti SD, Muller K (2016) Premature subclinical atherosclerosis in children and young adults with juvenile idiopathic arthritis. A review considering preventive measures. Pediatr Rheumatol Online J 14(1):3CrossRef Bohr AH, Fuhlbrigge RC, Pedersen FK, de Ferranti SD, Muller K (2016) Premature subclinical atherosclerosis in children and young adults with juvenile idiopathic arthritis. A review considering preventive measures. Pediatr Rheumatol Online J 14(1):3CrossRef
8.
Zurück zum Zitat Yeh KW, Lee CM, Chang CJ, Lin YJ, Huang JL (2014) Lipid profiles alter from pro-atherogenic into less atherogenic and proinflammatory in juvenile idiopathic arthritis patients responding to anti TNF-α treatment. PLoS One 9(6):e90757CrossRef Yeh KW, Lee CM, Chang CJ, Lin YJ, Huang JL (2014) Lipid profiles alter from pro-atherogenic into less atherogenic and proinflammatory in juvenile idiopathic arthritis patients responding to anti TNF-α treatment. PLoS One 9(6):e90757CrossRef
9.
Zurück zum Zitat Lefèvre-Utile A, Galeotti C, Koné-Paut I (2014) Coronary artery abnormalities in children with systemic-onset juvenile idiopathic arthritis. Jt Bone Spine 81(3):257–259CrossRef Lefèvre-Utile A, Galeotti C, Koné-Paut I (2014) Coronary artery abnormalities in children with systemic-onset juvenile idiopathic arthritis. Jt Bone Spine 81(3):257–259CrossRef
10.
Zurück zum Zitat Movva R, Brown SB, Morris DL, Figueredo VM (2013) Anakinra for myocarditis in juvenile idiopathic arthritis. Tex Heart Inst J 40(5):623–625PubMedPubMedCentral Movva R, Brown SB, Morris DL, Figueredo VM (2013) Anakinra for myocarditis in juvenile idiopathic arthritis. Tex Heart Inst J 40(5):623–625PubMedPubMedCentral
11.
Zurück zum Zitat Kuhl U, Pauschinger M, Schwimmbeck PL, Seeberg B, Lober C, Noutsias M et al (2003) Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107(22):2793–2798CrossRef Kuhl U, Pauschinger M, Schwimmbeck PL, Seeberg B, Lober C, Noutsias M et al (2003) Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107(22):2793–2798CrossRef
12.
Zurück zum Zitat Schultheiss HP, Kuhl U, Cooper LT (2011) The management of myocarditis. Eur Heart J 32(21):2616–2625CrossRef Schultheiss HP, Kuhl U, Cooper LT (2011) The management of myocarditis. Eur Heart J 32(21):2616–2625CrossRef
13.
Zurück zum Zitat Drucker NA, Colan SD, Lewis AB, Beiser AS, Wessel DL, Takahashi M et al (1994) Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation 89(1):252–257CrossRef Drucker NA, Colan SD, Lewis AB, Beiser AS, Wessel DL, Takahashi M et al (1994) Gamma-globulin treatment of acute myocarditis in the pediatric population. Circulation 89(1):252–257CrossRef
14.
Zurück zum Zitat Bharti BB, Kumar S, Kapoor A, Agarwal A, Mishra R, Sinha N (2004) Assessment of left ventricular systolic and diastolic function in juvenile rheumatoid arthritis. J Postgrad Med 50(4):262–265 (discussion 266-7) PubMed Bharti BB, Kumar S, Kapoor A, Agarwal A, Mishra R, Sinha N (2004) Assessment of left ventricular systolic and diastolic function in juvenile rheumatoid arthritis. J Postgrad Med 50(4):262–265 (discussion 266-7) PubMed
15.
Zurück zum Zitat Bultink IE, Lems WF, Dijkmans BA, van Soesbergen RM, Lindeman J (2002) Severe aortic regurgitation in RF positive polyarticular JIA. Ann Rheum Dis 61(3):282–283CrossRef Bultink IE, Lems WF, Dijkmans BA, van Soesbergen RM, Lindeman J (2002) Severe aortic regurgitation in RF positive polyarticular JIA. Ann Rheum Dis 61(3):282–283CrossRef
16.
Zurück zum Zitat Aubert S, Hayem G, Aumont MC, Brochet E, Acar C (2007) Valve repair for mitral insufficiency secondary to idiopathic juvenile polyarthritis. J Heart Valve Dis 16(3):324–327PubMed Aubert S, Hayem G, Aumont MC, Brochet E, Acar C (2007) Valve repair for mitral insufficiency secondary to idiopathic juvenile polyarthritis. J Heart Valve Dis 16(3):324–327PubMed
17.
Zurück zum Zitat Jiménez-Balderas FJ, García-Rubi D, Pérez-Hinojosa S, Arellano J, Yáñez P, Sanchez ML, Camargo-Coronel A, Zonana-Nacach A (2001) Two-dimensional echo Doppler findings in juvenile and adult onset ankylosing spondylitis with long-term disease. Angiology 52(8):543–548CrossRef Jiménez-Balderas FJ, García-Rubi D, Pérez-Hinojosa S, Arellano J, Yáñez P, Sanchez ML, Camargo-Coronel A, Zonana-Nacach A (2001) Two-dimensional echo Doppler findings in juvenile and adult onset ankylosing spondylitis with long-term disease. Angiology 52(8):543–548CrossRef
18.
Zurück zum Zitat Mavrogeni SI, Sfikakis PP, Dimitroulas T, Koutsogeorgopoulou L, Katsifis G, Markousis-Mavrogenis G, Kolovou G, Kitas GD (2018) Can cardiovascular magnetic resonance prompt early cardiovascular/rheumatic treatment in autoimmune rheumatic diseases? Current practice and future perspectives. Rheumatol Int 38(6):949–958CrossRef Mavrogeni SI, Sfikakis PP, Dimitroulas T, Koutsogeorgopoulou L, Katsifis G, Markousis-Mavrogenis G, Kolovou G, Kitas GD (2018) Can cardiovascular magnetic resonance prompt early cardiovascular/rheumatic treatment in autoimmune rheumatic diseases? Current practice and future perspectives. Rheumatol Int 38(6):949–958CrossRef
19.
Zurück zum Zitat Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31(11):1409–1417CrossRef Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31(11):1409–1417CrossRef
20.
Zurück zum Zitat Peters MJ, Symmons DP, McCarey D et al (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69:32531 Peters MJ, Symmons DP, McCarey D et al (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69:32531
21.
Zurück zum Zitat Shen CC, Yao TC, Yeh KW, Huang JL (2013) Association of disease activity and anti-rheumatic treatment in juvenile idiopathic arthritis with serum lipid profiles: a prospective study. Semin Arthritis Rheum 42(6):590–596CrossRef Shen CC, Yao TC, Yeh KW, Huang JL (2013) Association of disease activity and anti-rheumatic treatment in juvenile idiopathic arthritis with serum lipid profiles: a prospective study. Semin Arthritis Rheum 42(6):590–596CrossRef
22.
Zurück zum Zitat Coulson EJ, Ng WF, Goff I, Foster HE (2013) Cardiovascular risk in juvenile idiopathic arthritis. Rheumatology 52(7):1163–1171CrossRef Coulson EJ, Ng WF, Goff I, Foster HE (2013) Cardiovascular risk in juvenile idiopathic arthritis. Rheumatology 52(7):1163–1171CrossRef
23.
Zurück zum Zitat Mavrogeni S, Sfikakis PP, Gialafos E, Bratis K, Karabela G, Stavropoulos E, Spiliotis G, Sfendouraki E, Panopoulos S, Bournia V, Kolovou G, Kitas GD (2014) Cardiac tissue characterization and the diagnostic value of cardiovascular magnetic resonance in systemic connective tissue diseases. Arthritis Care Res (Hoboken) 66:104–112CrossRef Mavrogeni S, Sfikakis PP, Gialafos E, Bratis K, Karabela G, Stavropoulos E, Spiliotis G, Sfendouraki E, Panopoulos S, Bournia V, Kolovou G, Kitas GD (2014) Cardiac tissue characterization and the diagnostic value of cardiovascular magnetic resonance in systemic connective tissue diseases. Arthritis Care Res (Hoboken) 66:104–112CrossRef
24.
Zurück zum Zitat Mavrogeni S, Markousis-Mavrogenis G, Koutsogeorgopoulou L, Dimitroulas T, Bratis K, Kitas GD, Sfikakis P, Tektonidou M, Karabela G, Stavropoulos E, Katsifis G, Boki KA, Kitsiou A, Filaditaki V, Gialafos E, Plastiras S, Vartela V, Kolovou G (2017) Cardiovascular magnetic resonance imaging pattern at the time of diagnosis of treatment naïve patients with connective tissue diseases. Int J Cardiol 236:151–156CrossRef Mavrogeni S, Markousis-Mavrogenis G, Koutsogeorgopoulou L, Dimitroulas T, Bratis K, Kitas GD, Sfikakis P, Tektonidou M, Karabela G, Stavropoulos E, Katsifis G, Boki KA, Kitsiou A, Filaditaki V, Gialafos E, Plastiras S, Vartela V, Kolovou G (2017) Cardiovascular magnetic resonance imaging pattern at the time of diagnosis of treatment naïve patients with connective tissue diseases. Int J Cardiol 236:151–156CrossRef
25.
Zurück zum Zitat Mavrogeni SI, Kitas GD, Dimitroulas T, Sfikakis PP, Seo P, Gabriel S, Patel AR, Gargani L, Bombardieri S, Matucci-Cerinic M, Lombardi M, Pepe A, Aletras AH, Kolovou G, Miszalski T, Van Riel P, Semb A, Gonzalez-Gay MA, Dessein P, Karpouzas G, Puntman V, Nagel E, Bratis K, Karabela G, Stavropoulos E, Katsifis G, Koutsogeorgopoulou L, Van Rossum A, Rademakers F, Pohost G, Lima JAC (2016) Cardiovascular magnetic resonance in rheumatology: current status and recommendations for use. Int J Cardiol 217:135–148CrossRef Mavrogeni SI, Kitas GD, Dimitroulas T, Sfikakis PP, Seo P, Gabriel S, Patel AR, Gargani L, Bombardieri S, Matucci-Cerinic M, Lombardi M, Pepe A, Aletras AH, Kolovou G, Miszalski T, Van Riel P, Semb A, Gonzalez-Gay MA, Dessein P, Karpouzas G, Puntman V, Nagel E, Bratis K, Karabela G, Stavropoulos E, Katsifis G, Koutsogeorgopoulou L, Van Rossum A, Rademakers F, Pohost G, Lima JAC (2016) Cardiovascular magnetic resonance in rheumatology: current status and recommendations for use. Int J Cardiol 217:135–148CrossRef
26.
Zurück zum Zitat Mavrogeni S, Sfikakis PP, Karabela G, Stavropoulos E, Spiliotis G, Gialafos E, Panopoulos S, Bournia V, Manolopoulou D, Kolovou G, Kitas G (2014) Cardiovascular magnetic resonance imaging in asymptomatic patients with connective tissue disease and recent onset left bundle branch block. Int J Cardiol 171:82–87CrossRef Mavrogeni S, Sfikakis PP, Karabela G, Stavropoulos E, Spiliotis G, Gialafos E, Panopoulos S, Bournia V, Manolopoulou D, Kolovou G, Kitas G (2014) Cardiovascular magnetic resonance imaging in asymptomatic patients with connective tissue disease and recent onset left bundle branch block. Int J Cardiol 171:82–87CrossRef
27.
Zurück zum Zitat Kobayashi Y, Kobayashi H, Giles JT, Hirano M, Nakajima Y, Takei M (2016) Association of tocilizumab treatment with changes in measures of regional left ventricular function in rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging. Int J Rheum Dis 19:1169–1174CrossRef Kobayashi Y, Kobayashi H, Giles JT, Hirano M, Nakajima Y, Takei M (2016) Association of tocilizumab treatment with changes in measures of regional left ventricular function in rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging. Int J Rheum Dis 19:1169–1174CrossRef
28.
Zurück zum Zitat Mayr A, Kitterer D, Latus J, Steubing H, Henes J, Vecchio F, Kaesemann P, Patrascu A, Greiser A, Groeninger S, Braun N, Alscher MD, Sechtem U, Mahrholdt H, Greulich S (2016) Evaluation of myocardial involvement in patients with connective tissue disorders: a multi-parametric cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 18:1–13 Mayr A, Kitterer D, Latus J, Steubing H, Henes J, Vecchio F, Kaesemann P, Patrascu A, Greiser A, Groeninger S, Braun N, Alscher MD, Sechtem U, Mahrholdt H, Greulich S (2016) Evaluation of myocardial involvement in patients with connective tissue disorders: a multi-parametric cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 18:1–13
29.
Zurück zum Zitat Mavrogeni S, Markousis-Mavrogenis G, Koutsogeorgopoulou L, Kolovou G (2017) Cardiovascular magnetic resonance imaging: clinical implications in the evaluation of connective tissue diseases. J Inflamm Res 10:55–61CrossRef Mavrogeni S, Markousis-Mavrogenis G, Koutsogeorgopoulou L, Kolovou G (2017) Cardiovascular magnetic resonance imaging: clinical implications in the evaluation of connective tissue diseases. J Inflamm Res 10:55–61CrossRef
30.
Zurück zum Zitat Abdel-Aty H, Boyé P, Zagrosek A, Wassmuth R, Kumar A, Messroghli D, Bock P, Dietz R, Friedrich MG, Schulz-Menger J (2005) Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 45(11):1815–1822CrossRef Abdel-Aty H, Boyé P, Zagrosek A, Wassmuth R, Kumar A, Messroghli D, Bock P, Dietz R, Friedrich MG, Schulz-Menger J (2005) Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 45(11):1815–1822CrossRef
31.
Zurück zum Zitat Maceira AM, Monmeneu JV, Igual-Muñoz B, Lopez-Lereu PM, Garcia PM, Cosin J (2015) Reference values for regional and global myocardial T2 mapping with cardiovascular magnetic resonance at 1.5T and 3T. J Cardiovasc Magn Reson 17(Suppl 1):P12CrossRef Maceira AM, Monmeneu JV, Igual-Muñoz B, Lopez-Lereu PM, Garcia PM, Cosin J (2015) Reference values for regional and global myocardial T2 mapping with cardiovascular magnetic resonance at 1.5T and 3T. J Cardiovasc Magn Reson 17(Suppl 1):P12CrossRef
32.
Zurück zum Zitat Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, White JA, Abdel-Aty H, Gutberlet M, Prasad S, Aletras A, Laissy JP, Paterson I, Filipchuk NG, Kumar A, Pauschinger M, Liu P, International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis (2009) Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol. 53(17):1475–1487CrossRef Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, White JA, Abdel-Aty H, Gutberlet M, Prasad S, Aletras A, Laissy JP, Paterson I, Filipchuk NG, Kumar A, Pauschinger M, Liu P, International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis (2009) Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol. 53(17):1475–1487CrossRef
33.
Zurück zum Zitat Ong P, Athansiadis A, Hill S, Kispert EM, Borgulya G, Klingel K, Kandolf R, Sechtem U, Mahrholdt H (2011) Usefulness of pericardial effusion as new diagnostic criterion for noninvasive detection of myocarditis. Am J Cardiol. 108:445–452CrossRef Ong P, Athansiadis A, Hill S, Kispert EM, Borgulya G, Klingel K, Kandolf R, Sechtem U, Mahrholdt H (2011) Usefulness of pericardial effusion as new diagnostic criterion for noninvasive detection of myocarditis. Am J Cardiol. 108:445–452CrossRef
34.
Zurück zum Zitat Nathan M, Ying LC, Pierre C, Blumke D, Lima J (2011) Assessment of myocardial fibrosis with cardiac magnetic resonance. J Am Coll Cardiol 57(8):891–903CrossRef Nathan M, Ying LC, Pierre C, Blumke D, Lima J (2011) Assessment of myocardial fibrosis with cardiac magnetic resonance. J Am Coll Cardiol 57(8):891–903CrossRef
35.
Zurück zum Zitat Sado DM, Flett AS, Banypersad SM, White SK, Maestrini V, Quarta G, Lachmann RH, Murphy E, Mehta A, Hughes DA, McKenna WJ, Taylor AM, Hausenloy DJ, Hawkins PN, Elliott PM, Moon JC (2012) Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart 98:1436–1441CrossRef Sado DM, Flett AS, Banypersad SM, White SK, Maestrini V, Quarta G, Lachmann RH, Murphy E, Mehta A, Hughes DA, McKenna WJ, Taylor AM, Hausenloy DJ, Hawkins PN, Elliott PM, Moon JC (2012) Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart 98:1436–1441CrossRef
36.
Zurück zum Zitat Schalla S, Nagel E, Lehmkuhl H, Klein C, Bornstedt A, Schnackenburg B et al (2001) Comparison of magnetic resonance real-time imaging of LV function with conventional magnetic resonance imaging and echocardiography. Am J Cardiol 87:95–99CrossRef Schalla S, Nagel E, Lehmkuhl H, Klein C, Bornstedt A, Schnackenburg B et al (2001) Comparison of magnetic resonance real-time imaging of LV function with conventional magnetic resonance imaging and echocardiography. Am J Cardiol 87:95–99CrossRef
37.
Zurück zum Zitat Bottini PB, Carr AA, Prisant M et al (1995) Magnetic resonance imaging compared to echo/phy to assess LV MASS in the hypertensive patient. Am J Hypertens 8:221–226CrossRef Bottini PB, Carr AA, Prisant M et al (1995) Magnetic resonance imaging compared to echo/phy to assess LV MASS in the hypertensive patient. Am J Hypertens 8:221–226CrossRef
38.
Zurück zum Zitat Mavrogeni SI, Kitas GD, Dimitroulas T, Sfikakis PP, Seo P, Gabriel S, Patel AR, Gargani L, Bombardieri S, Matucci-Cerinic M, Lombardi M, Pepe A, Aletras AH, Kolovou G, Miszalski T, van Riel P, Semb A, Gonzalez-Gay MA, Dessein P, Karpouzas G, Puntmann V, Nagel E, Bratis K, Karabela G, Stavropoulos E, Katsifis G, Koutsogeorgopoulou L, van Rossum A, Rademakers F, Pohost G, Lima JA (2016) Cardiovascular magnetic resonance in rheumatology: current status and recommendations for use. Int J Cardiol 217:135–148CrossRef Mavrogeni SI, Kitas GD, Dimitroulas T, Sfikakis PP, Seo P, Gabriel S, Patel AR, Gargani L, Bombardieri S, Matucci-Cerinic M, Lombardi M, Pepe A, Aletras AH, Kolovou G, Miszalski T, van Riel P, Semb A, Gonzalez-Gay MA, Dessein P, Karpouzas G, Puntmann V, Nagel E, Bratis K, Karabela G, Stavropoulos E, Katsifis G, Koutsogeorgopoulou L, van Rossum A, Rademakers F, Pohost G, Lima JA (2016) Cardiovascular magnetic resonance in rheumatology: current status and recommendations for use. Int J Cardiol 217:135–148CrossRef
39.
Zurück zum Zitat Chiribiri A, Botnar RM, Nagel E (2013) Magnetic resonance coronary angiography: where are we today? Curr Cardiol Rep 15(2):328CrossRef Chiribiri A, Botnar RM, Nagel E (2013) Magnetic resonance coronary angiography: where are we today? Curr Cardiol Rep 15(2):328CrossRef
40.
Zurück zum Zitat Mavrogeni S, Manoussakis MN, Karagiorga TC, Douskou M, Panagiotakos D, Bournia V, Cokkinos DV, Moutsopoulos HM (2009) Detection of coronary artery lesions and myocardial necrosis by magnetic resonance in systemic necrotizing vasculitides. Arthritis Rheum 61(8):1121–1129CrossRef Mavrogeni S, Manoussakis MN, Karagiorga TC, Douskou M, Panagiotakos D, Bournia V, Cokkinos DV, Moutsopoulos HM (2009) Detection of coronary artery lesions and myocardial necrosis by magnetic resonance in systemic necrotizing vasculitides. Arthritis Rheum 61(8):1121–1129CrossRef
41.
Zurück zum Zitat Terashima M, Nguyen PK, Rubin GD, Meyer CH, Shimakawa A, Nishimura DG, Ehara S, Iribarren C, Courtney BK, Go AS, Hlatky MA, Fortmann SP, McConnell MV (2010) Right coronary wall CMR in the older asymptomatic advance cohort: positive remodeling and associations with type 2 diabetes and coronary calcium. J Cardiovasc Magn Reson 12:75CrossRef Terashima M, Nguyen PK, Rubin GD, Meyer CH, Shimakawa A, Nishimura DG, Ehara S, Iribarren C, Courtney BK, Go AS, Hlatky MA, Fortmann SP, McConnell MV (2010) Right coronary wall CMR in the older asymptomatic advance cohort: positive remodeling and associations with type 2 diabetes and coronary calcium. J Cardiovasc Magn Reson 12:75CrossRef
42.
Zurück zum Zitat Kim WY, Astrup AS, Stuber M, Tarnow L, Falk E, Botnar RM, Simonsen C, Pietraszek L, Hansen PR, Manning WJ, Andersen NT, Parving HH (2007) Subclinical coronary and aortic atherosclerosis detected by magnetic resonance imaging in type 1 diabetes with and without diabetic nephropathy. Circulation 115(2):228–235CrossRef Kim WY, Astrup AS, Stuber M, Tarnow L, Falk E, Botnar RM, Simonsen C, Pietraszek L, Hansen PR, Manning WJ, Andersen NT, Parving HH (2007) Subclinical coronary and aortic atherosclerosis detected by magnetic resonance imaging in type 1 diabetes with and without diabetic nephropathy. Circulation 115(2):228–235CrossRef
43.
Zurück zum Zitat Schwitter J (2006) Myocardial perfusion imaging by cardiac magnetic resonance. J Nucl Cardiol 13:841–854 (21) CrossRef Schwitter J (2006) Myocardial perfusion imaging by cardiac magnetic resonance. J Nucl Cardiol 13:841–854 (21) CrossRef
44.
Zurück zum Zitat Schwitter J, Nanz D, Kneifel S, Bertschinger K, Buchi M, Knusel PR, Marincek B, Luscher TF, von Schulthess GK (2001) Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation 103:2230–2235CrossRef Schwitter J, Nanz D, Kneifel S, Bertschinger K, Buchi M, Knusel PR, Marincek B, Luscher TF, von Schulthess GK (2001) Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography. Circulation 103:2230–2235CrossRef
45.
Zurück zum Zitat Plein S, Ryf S, Schwitter J, Radjenovic A, Boesiger P, Kozerke S (2007) Dynamic contrast-enhanced myocardial perfusion MRI accelerated with k-t sense. Magn Reson Med 58:777–785CrossRef Plein S, Ryf S, Schwitter J, Radjenovic A, Boesiger P, Kozerke S (2007) Dynamic contrast-enhanced myocardial perfusion MRI accelerated with k-t sense. Magn Reson Med 58:777–785CrossRef
46.
Zurück zum Zitat Gebker R, Jahnke C, Paetsch I, Kelle S, Schnackenburg B, Fleck E, Nagel E (2008) Diagnostic performance of myocardial perfusion MR at 3 T in patients with coronary artery disease. Radiology 247:57–63CrossRef Gebker R, Jahnke C, Paetsch I, Kelle S, Schnackenburg B, Fleck E, Nagel E (2008) Diagnostic performance of myocardial perfusion MR at 3 T in patients with coronary artery disease. Radiology 247:57–63CrossRef
47.
Zurück zum Zitat Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, Bijsterveld P, Ridgway JP, Radjenovic A, Dickinson CJ, Ball SG, Plein S (2012) Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet 379:453–460CrossRef Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, Bijsterveld P, Ridgway JP, Radjenovic A, Dickinson CJ, Ball SG, Plein S (2012) Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet 379:453–460CrossRef
48.
Zurück zum Zitat Gargiulo P, Dellegrottaglie S, Bruzzese D, Savarese G, Scala O, Ruggiero D, D’Amore C, Paolillo S, Agostoni P, Bossone E, Soricelli A, Cuocolo A, Trimarco B, Filardi PP (2013) The prognostic value of normal stress cardiac magnetic resonance in patients with known or suspected coronary artery disease: a meta-analysis. Circ Cardiovasc Imaging 6(4):574–582CrossRef Gargiulo P, Dellegrottaglie S, Bruzzese D, Savarese G, Scala O, Ruggiero D, D’Amore C, Paolillo S, Agostoni P, Bossone E, Soricelli A, Cuocolo A, Trimarco B, Filardi PP (2013) The prognostic value of normal stress cardiac magnetic resonance in patients with known or suspected coronary artery disease: a meta-analysis. Circ Cardiovasc Imaging 6(4):574–582CrossRef
49.
Zurück zum Zitat Kobayashi H, Kobayashi Y, Yokoe I, Akashi Y, Takei M, Giles JT (2017) Magnetic resonance imaging-detected myocardial inflammation and fibrosis in rheumatoid arthritis: associations with disease characteristics and N-terminal Pro-brain natriuretic peptide levels. Arthritis Care Res (Hoboken) 69(9):1304–1311CrossRef Kobayashi H, Kobayashi Y, Yokoe I, Akashi Y, Takei M, Giles JT (2017) Magnetic resonance imaging-detected myocardial inflammation and fibrosis in rheumatoid arthritis: associations with disease characteristics and N-terminal Pro-brain natriuretic peptide levels. Arthritis Care Res (Hoboken) 69(9):1304–1311CrossRef
50.
Zurück zum Zitat Holmström M, Koivuniemi R, Korpi K, Kaasalainen T, Laine M, Kuuliala A, Leirisalo-Repo M, Kupari M, Kivistö S (2016) Cardiac magnetic resonance imaging reveals frequent myocardial involvement and dysfunction in active rheumatoid arthritis. Clin Exp Rheumatol 34(3):416–423PubMed Holmström M, Koivuniemi R, Korpi K, Kaasalainen T, Laine M, Kuuliala A, Leirisalo-Repo M, Kupari M, Kivistö S (2016) Cardiac magnetic resonance imaging reveals frequent myocardial involvement and dysfunction in active rheumatoid arthritis. Clin Exp Rheumatol 34(3):416–423PubMed
51.
Zurück zum Zitat Mavrogeni S, Bratis K, Koutsogeorgopoulou L, Karabela G, Savropoulos E, Katsifis G, Raftakis J, Markousis-Mavrogenis G, Kolovou G (2017) Myocardial perfusion in peripheral Raynaud’s phenomenon. Evaluation using stress cardiovascular magnetic resonance. Int J Cardiol 228:444–448CrossRef Mavrogeni S, Bratis K, Koutsogeorgopoulou L, Karabela G, Savropoulos E, Katsifis G, Raftakis J, Markousis-Mavrogenis G, Kolovou G (2017) Myocardial perfusion in peripheral Raynaud’s phenomenon. Evaluation using stress cardiovascular magnetic resonance. Int J Cardiol 228:444–448CrossRef
52.
Zurück zum Zitat Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; Authors/Task Force Members; Document Reviewers (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 18(8):891–975CrossRef Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; Authors/Task Force Members; Document Reviewers (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 18(8):891–975CrossRef
Metadaten
Titel
The emerging role of cardiovascular magnetic resonance imaging in the assessment of cardiac involvement in juvenile idiopathic arthritis
verfasst von
Sophie Mavrogeni
Lambros Fotis
Loukia Koutsogeorgopoulou
Vasiliki Vartela
Vana Papaevangelou
Genovefa Kolovou
Publikationsdatum
06.06.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 8/2018
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-018-4078-1

Weitere Artikel der Ausgabe 8/2018

Rheumatology International 8/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.